Combinations for diabetes
US6011049A · kind A · utility
135Cited by
0References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 9, 1998 |
| Grant date | Jan 4, 2000 |
| Priority date | — |
| Expiry date | Nov 9, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Combinations of a glitazone antidiabetic agent and a biguanide antidiabetic agent, and optionally a sulfonylurea antidiabetic agent, are useful for treating diabetes mellitus and improving glycemic control.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.